Biologics · 2014 · 11 citations · 25 references
MedicineCancer BiologyOncologyCancer GeneticsDna RepairMolecular OncologyAdverse Effects Of ChemotherapyAnthracycline CardiotoxicityCancer EpigeneticsChemotherapy ResistanceCytotoxic ChemotherapyMolecular Mechanisms Of ToxicityAnthracycline-based ChemotherapyAnthracycline-induced CardiotoxicityAntineoplastic Drug TherapyCardiotoxicityChemotherapy-related ToxicityChromatin RemodelingDoxorubicin CardiotoxicityDoxorubicin-based Therapy
The SWI/SNF chromatin-remodeling complex plays an essential role in several cellular processes including cell proliferation, differentiation, and DNA repair. Loss of normal function of the SWI/SNF complex because of mutations in its subunits correlates with tumorigenesis in humans. For many of these cancers, cytotoxic chemotherapy is the primary, and sometimes the only, therapeutic alternative. Among the antineoplastic agents, anthracyclines are a common treatment option. Although effective, resistance to these agents usually develops and serious dose-related toxicity, namely, chronic cardiotoxicity, limits its use. Previous work from our laboratory showed that a deletion of the SWI/SNF factor SNF2 resulted in hypersensitivity to doxorubicin. We further investigated the contribution of other chromatin remodeling complex components in the response to cytotoxic chemotherapy. Our results indicate that, of the eight SWI/SNF strains tested, snf2, taf14, and swi3 were the most sensitive and displayed distinct sensitivity to different cytotoxic agents, while snf5 displayed resistance. Our experimental results indicate that the SWI/SNF complex plays a critical role in protecting cells from exposure to cytotoxic chemotherapy and other cytotoxic agents. Our findings may prove useful in the development of a strategy aimed at targeting these genes to provide an alternative by hypersensitizing cancer cells to chemotherapeutic agents.
25
Laurie Issel‐Tarver, Karen Christie, Kara Dolinski et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2002 · 672 citations
Daniel X. Tishkoff, Adrienne L. Boerger, Pascale Bertrand et al. · Proceedings of the National Academy of Sciences · 1997 · 385 citations · Full text
Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
Julie Gehl, Michael W. Boesgaard, T Paaske et al. · Annals of Oncology · 1996 · 250 citations · Full text
Medicine, Oncology, Pharmacology +12